Novo Nordisk stock has dived this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff by Hims & ...

Strategy stock jumped 8% early Friday as it looked set to regain some ground after slumping 17% to its lowest close in two ...

Iran's Foreign Minister Abbas Araghchi criticises what he says is a "doctrine of domination" that allows Israel to expand its military arsenal while pressuring others to disarm. His remarks come a day ...

If marquee, public software companies like Salesforce, ServiceNow, and Workday are getting hammered by concerns about AI, ...

Nvidia is suffering amid the stock market’s tech selloff. Amazon.com enormous spending should probably be good news for the ...

The acquisition of Meritage Portfolio Management expands the North Carolina-based aggregator’s presence in the Midwest.

Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe to Barron's, click here. If you're a wealth managment professional and ...

The Department of Health and Human Services referred the consumer wellness company to the Department of Justice for investigation, wrote HHS general counsel Mike Stuart in a post on X Friday afternoon ...

The Bitcoin rout continues, one IPO pauses while three more move ahead, Hims & Hers offers knockoff Wegovy pill, and more ...

The Dow Jones Industrial Average rode a resurgence in risk appetite north of 50,000 on Friday. The blue-chip index surged 1,206 points, or 2.5%, to close above 50,000 for the first time. The S&P 500 ...

The price of Bitcoin, Ethereum, and XRP have all tumbled in recent days amid a brutal crypto selloff.